These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34755831)

  • 1. Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.
    Pickel L; Iliuta IA; Scholey J; Pei Y; Sung HK
    Adv Nutr; 2022 Mar; 13(2):652-666. PubMed ID: 34755831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence.
    Pezzuoli C; Biagini G; Magistroni R
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic Kidney Disease Diet: What is Known and What is Safe.
    Chebib FT; Nowak KL; Chonchol MB; Bing K; Ghanem A; Rahbari-Oskoui FF; Dahl NK; Mrug M
    Clin J Am Soc Nephrol; 2024 May; 19(5):664-682. PubMed ID: 37729939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.
    Nowak KL; Hopp K
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):577-584. PubMed ID: 32086281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Add-On Benefits of Dietary Intervention in the Treatment of Autosomal Dominant Polycystic Kidney Disease.
    Rosati E; Condello G; Tacente C; Mariani I; Tommolini V; Calvaruso L; Fulignati P; Grandaliano G; Pesce F
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature.
    Capelli I; Lerario S; Aiello V; Provenzano M; Di Costanzo R; Squadrani A; Vella A; Vicennati V; Poli C; La Manna G; Baraldi O
    Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression.
    Messing M; Torres JA; Holznecht N; Weimbs T
    Nutrients; 2024 Sep; 16(19):. PubMed ID: 39408247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't.
    Ong ACM; Torra R
    Clin Kidney J; 2022 Jun; 15(6):1034-1036. PubMed ID: 35664267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease.
    Oehm S; Steinke K; Schmidt J; Arjune S; Todorova P; Heinrich Lindemann C; Wöstmann F; Meyer F; Siedek F; Weimbs T; Müller RU; Grundmann F
    Nephrol Dial Transplant; 2023 Jun; 38(7):1623-1635. PubMed ID: 36423335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is autosomal dominant polycystic kidney disease an early sweet disease?
    Dachy A; Decuypere JP; Vennekens R; Jouret F; Mekahli D
    Pediatr Nephrol; 2022 Sep; 37(9):1945-1955. PubMed ID: 34988697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.
    Kipp KR; Rezaei M; Lin L; Dewey EC; Weimbs T
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F726-F731. PubMed ID: 26764208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects.
    Strubl S; Oehm S; Torres JA; Grundmann F; Haratani J; Decker M; Vuong S; Kaur Bhandal A; Methot N; Haynie-Cion R; Meyer F; Siedek F; Korst U; Müller RU; Weimbs T
    Clin Kidney J; 2022 Jun; 15(6):1079-1092. PubMed ID: 35664270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial.
    Cukoski S; Lindemann CH; Arjune S; Todorova P; Brecht T; Kühn A; Oehm S; Strubl S; Becker I; Kämmerer U; Torres JA; Meyer F; Schömig T; Hokamp NG; Siedek F; Gottschalk I; Benzing T; Schmidt J; Antczak P; Weimbs T; Grundmann F; Müller RU
    Cell Rep Med; 2023 Nov; 4(11):101283. PubMed ID: 37935200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic approaches to autosomal dominant polycystic kidney disease.
    LaRiviere WB; Irazabal MV; Torres VE
    Transl Res; 2015 Apr; 165(4):488-98. PubMed ID: 25438190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice.
    Meijer E; Gansevoort RT
    Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):482-492. PubMed ID: 34261861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Care for ADPKD Patients: Current Status and Future Directions.
    Carriazo S; Perez-Gomez MV; Cordido A; García-González MA; Sanz AB; Ortiz A; Sanchez-Niño MD
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease.
    Stayner C; Brooke DG; Bates M; Eccles MR
    Curr Med Chem; 2019; 26(17):3081-3102. PubMed ID: 29737248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.
    Corradi V; Gastaldon F; Virzì GM; Caprara C; Martino F; Ronco C
    Minerva Med; 2015 Feb; 106(1):53-64. PubMed ID: 25300895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans.
    Magistroni R; Boletta A
    J Nephrol; 2017 Aug; 30(4):511-519. PubMed ID: 28390001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.